Mini Review - Journal of Pharmaceutical Research and Clinical Practice (2022) Volume 5, Issue 4

Cardiac Development in Zebra Fish through the Retinoic Acid Signaling Pathway

Delgado M J*

Shanghai Cardiovascular Disease Institute, Sudan University, Shanghai 200032, Cameroon

*Corresponding Author:
Delgado M J
Shanghai Cardiovascular Disease Institute, Sudan University, Shanghai 200032, Cameroon
a E-mail:

Received: 01-Aug-2022, Manuscript No. JPRCP-22-72595; Editor assigned: 04-Aug-2022, PreQC No. JPRCP-22-72595 (PQ); Reviewed: 18- Aug-2022, QC No. JPRCP-22-72595; Revised: 22-Aug-2022, Manuscript No. JPRCP-22-72595 (R); Published: 29-Aug-2022, DOI: 10.37532/jprcp.2022.5(4).79-82


Adipose acid- binding protein 3(FABP3) is a member of the intracellular lipid- binding protein family, and is primarily expressed in cardiac muscle towel. Preliminarily, we set up that FABP3 is largely expressed in cases with ventricular- septal blights and is frequently used as a tube biomarker in idiopathic ballooned cardiomyopathy, and may play a significant part in the development of these blights in humans. In the present study, we aimed to probe the part of FABP3 in the embryonic development of the zebra fish heart, and specifically how morphine (MO) intermediated knockdown of FABP3 would affect heart development in this species. Our results revealed that knockdown of FABP3 caused significant impairment of cardiac development observed, including experimental detention, pericardial edema, a direct heart tube phenotype, deficient cardiac circle conformation, abnormal positioning.


FABP3 • Zebra fish • Cardiac development • RA


The heart is the first organ to form and serve during invertebrate embryonic development. Natural heart complaint is an important element of pediatric cardiovascular complaint present at birth, and constitutes a major chance of clinically significant birth blights, with an estimated frequency of 4 – 50 per 1000 live births. Natural heart blights do in nearly 1 of live births, reflecting the complex cellular processes underpinnings heart development. Cardiac development requires a precise and extremely complex series of molecular mechanisms to orchestrate the proper expression of cardiac recap factors, and differences in their expression can affect in heart blights [1]. Classical forward inheritable mortal birth studies have therefore far handed limited sapience into the inheritable causes of natural heart blights. Preliminarily, McCann et al. Set up that adipose acid- binding protein 3 (FABP3; also appertained to as heart- type adipose acidbinding protein) could be used as a new tube biomarker in the early opinion of acute ischemic casket pain. Before, our group also established that FABP3 is up regulated in cases with ventricularseptal blights in comparison to normal controls, by using subtractive hybridization. We’ve also reported that down- regulation of FABP3 expression promotes cell apoptosis and causes mitochondrial dysfunction in P19 cells [2]. Interestingly, FABP3 has been shown to be up regulated during terminal isolation of mouse cardiomyocytes. Taken together these studies suggest that FABP3 may play an important part in cardiac development; still, definitive data is lacking. While cellular receptors for RVC are unknown, target cell surface carbohydrates, including histo-blood-group antigens (HBGAs) and sialic acids (SAs), are believed to play a role in cell attachment/entry. The evaluation of the selective binding of RVCs to different HBGAs revealed that PRVC Cowden G1P [3] replicated to the highest titers in the HBGA-A PIEs, while PRVC104 or PRVC143 achieved the highest titers in the HBGA-H PIEs. Further, contrasting outcomes were observed following sialidase treatment (resulting in terminal SA removal), which significantly enhanced Cowden and RVC143 replication, but inhibited the growth of PRVC104. These observations suggest that different RVC strains may recognize terminal (PRVC104) as well as internal (Cowden and RVC143) SAs on gangliosides. Finally, several cell culture additives, such as diethylaminoethyl (DEAE)-dextran, cholesterol, and bile extract, were tested to establish if they could enhance RVC replication. We observed that only DEAE-dextran significantly enhanced RVC attachment, but it had no effect on RVC replication. Additionally, the depletion of cellular cholesterol by MβCD inhibited Cowden replication, while the restoration of the cellular cholesterol partially reversed the MβCD effects. These results suggest that cellular cholesterol plays an important role in the replication of the PRVC strain tested [4]. Overall, our study has established a novel robust and physiologically relevant system to investigate RVC pathogenesis. We also generated novel, experimentally derived evidence regarding the role of host glycans, DEAE, and cholesterol in RVC replication, which is critical for the development of control strategies. [5] Suffering acute Toxin at each treatment attention was calculated. the rate of lethality performing from FABP3- MO at a cure of1.0 mg up to 120 hpf was no further than 15 compared with Wt. MO and then on-injected control group. In discrepancy, the rates of lethality performing from FABP3- MO tablets at2.5 mg and5.0 mg were22.0 and37.7 at 120 hpf, independently. When embryos were treated with7.5 mg and10.0 mg FABP3- MO, the rate of lethality exceeded 70 and 97, independently, making it insolvable to observe heart development during after stages of development. Also, when advanced attentions of FABP3- MO were coupled with longer observation times, the rate of lethality among treated embryos increased mainly. Grounded on our methodical disquisition of MO cure and the attendant effect on embryo lethality, we fitted FABP3- MO at a lozenge of5.0 mg to probe the influence of FABP3 on cardiac development [6]. RVs are non-enveloped double-stranded RNA (dsRNA) viruses that contain 11 segments of dsRNA encoding for structural and nonstructural proteins: VP1-VP4, VP6, VP7, and NSP1-5/6. RVs are classified into nine antigenically and genetically distinct groups according to the International Committee on the Taxonomy of Viruses (ICTV, https://talk., accessed on 16 August 2022), designated as RVA, RVB, RVC, RVD, RVF, RVG, RVH, RVI, and RVJ. Within each group, RVs are further classified into G and P genotypes based on the molecular characteristics of their outer surface glycoprotein VP7 and the protease-sensitive spike protein VP4 (cleaved into VP8* and VP5* under protease treatment), respectively [7]. RVA has been studied extensively and historically considered the most prevalent and pathogenic among the nine RV groups. RVCs are emerging pathogens increasingly reported in pigs and humans worldwide and are currently recognized as the major cause of gastroenteritis in neonatal piglet. RVCs have been documented as single or mixed infections with other enteric pathogens in nursing, weaning, and post-weaning pigs. Single RVC infections are being increasingly identified in association with diarrhea in very young suckling piglets, and higher RVC RNA titers are significantly associated with diarrhea in piglets. Moreover, seroepidemiological studies in pigs indicated that RVCs have been circulating in swine herds in different countries for many decades, reaching seroprevalence rates of 58– 100% [8]. Recent studies demonstrated very high prevalence and significant genetic diversity of porcine RVCs in different countries. Despite the increasing importance of RVCs, our knowledge of RVC pathogenesis is still limited due to the lack of a robust cell culture system for most RVC strains and only a few studies focusing on RVC pathogenesis [9]. Notwithstanding significant efforts made to develop a suitable in vitro culture system, the porcine RVC Cowden strain was the first of only a few cultivable RVCs that can be serially propagated in porcine kidney cell cultures and are characterized by modest replication titers. Thus, the development of a suitable and robust cell culture system is essential to understand the basic virology, pathogenesis, and innate immune and other cellular responses induced by RVCs [10]. In the last decade, zebra fish have been used as an important model to study cardiac development. The mechanisms of zebra fish development are allowed to be analogous to mammals; therefore an bettered understanding of zebra fish development can be related to experimental mechanisms in these creatures. The zebra fish embryonic attributes compound the feasibility of conducting classical inheritable defenses that affect cardiac development. Therefore, we used zebra fish as a model to probe the FABP3 in cardiac development. We’ve preliminarily reported that FABP3 is largely expressed in cases with ventricular- septal blights, when compared with normal controls [11]. This and other compliances led us to hypothecate that FABP3 might play an important part in cardiac development. In the present study, cardiac development was explored in FABP3- MO fitted zebra fish embryos and the attendant zebra fish heart blights were further studied at the molecular position. After establishing that our FABP3- MO led to knockdown of FABP3 in zebra fish embryos, we performed a methodical disquisition of zebra fish heart development. We set up that injection of FABP3- MO mainly increased the rate of embryonic lethality in a cure-dependent manner. Grounded on these primary studies, a cure of5.0 mg of FABP3- MO was chosen to study the effect of FABP3 knockdown in heart development. To minimize off- target goods and strengthen the impact of the observed heart phenotype, we designed the splice- Morpholine of FABP3 (FABP3- MO2) and observed the heart phenotype. At a cure of5.0 mg MO, we set up embryonic or naiads deformations, experimental detention, lower heads, abnormal eye development, pericardial edema and a direct heart tube phenotype in FABP3- MO fitted zebra fish. We interpreted these results to indicate that FABP3 can impact the development of zebra fish, especially with regard to the heart. [12]


In summary, we’ve set up that knockdown of FABP3 causes blights in zebra fish embryonic development, including experimental detention, pericardial edema, and a direct heart tube phenotype. Knockdown of FABP3 had particularly significant poisonous goods on cardiac development, similar as deficient heart looping and abnormal positioning of the ventricles and gallerias, which was accompanied by down regulated expression of cardiac-specific genes. Our mechanistic data indicated that the beginning molecular medium for these blights could be associated with deregulated RA signaling. We conclude that knockdown of FABP3 has poisonous goods on zebra fish embryogenesis, impeding normal heart development through the RA signaling pathway. Farther analysis of the relationship between RA signaling and cardiacspecific recap factor expression may clarify the medium which leads to abnormal heart development in embryos with dropped FABP3 expression. Intestinal asteroids (IEs) are in vitro, three-dimensional (3D) culture systems that recapitulate the complex nature and functions of the gut. IEs are isolated from epithelial stem cells residing in small intestinal crypts and cultured in Wnt3A-rich growth medium and Matrigel, which support their 3D structure. The crypt cells give rise to stem and transient amplifying cells, and all of the small intestinal differentiated epithelial cell lineages, including enterocytes, enter endocrine cells, goblet cells, and Praneeth cells, identified in humans, mice, and pigs [13]. Tuft cells, which represent approximately 1% of the total epithelial cell population, are also reported to exist in IEs. IEs have recently demonstrated tremendous potential as a model to study pathogen–host interactions, including norovirus, porcine epidemic diarrhea virus (PEDV), porcine delta coronavirus (PDCoV), severe acute respiratory syndrome coronavirus 2, and RV. Importantly, IEs express glycan receptors, such as sialic acids (SAs), and histoblood- group antigens (HBGAs), which make them an indispensable in vitro model to investigate the host glycan–RV interactions and dissect the mechanisms of RV cell entry [14-15].



Conflict of Interest

No conflict of interest


  1. Hoffman JI. Congenital heart disease: Incidence and inheritance. Pediatr Clin N Am. 37, 25–43(1990).
  2. Indexed at, Google Scholar, Crossref

  3. Moller JH, Allen HD, Clark EB et al. Report of the task force on children and youth. American Heart Association. Circulation. 88, 2479–2486(1993).
  4. Indexed at, Google Scholar, Crossref

  5. Bruneau BG. The developmental genetics of congenital heart disease. Nature. 451, 943–948(2008).
  6. Indexed at, Google Scholar, Crossref

  7. Nemer M. Genetic insights into normal and abnormal heart development Cardiovasc. Pathol. 17, 48–54(2008).
  8. Indexed at, Google Scholar, Crossref

  9. Srivastava D, Olson EN. A genetic blueprint for cardiac development. Nature. 407, 221–226(2000).
  10. Indexed at, Google Scholar, Crossref

  11. Luchini C, Pea A, Scarpa A. Artificial intelligence in oncology: Current applications and future perspectives. Br J Cancer. 126, 4–9(2022).
  12. Indexed at, Google Scholar, Crossref

  13. Shapiro Charles L. Cancer Survivorship. N Engl J Med. 379, 2438–2450 (2018).
  14. Indexed at, Google Scholar, Crossref

  15. Lu C, Bera K, Wang X et al. A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: A multicentre, retrospective study. Lancet Digit Health. 2, 594–606 (2020).
  16. Indexed at, Google Scholar, Crossref

  17. Singla N, Singla S. Harnessing Big Data with Machine Learning in Precision Oncology. Kidney Cancer J. 18, 83–84(2020).
  18. Indexed at, Google Scholar

  19. Mu W, Jiang L, Zhang J et al. Non-invasive decision support for NSCLC treatment using PET/CT radiomics. Nat Commun. 11, 5228 (2020).
  20. Indexed at, Google Scholar, Crossref

  21. Bera K, Schalper KA, Rimm DL et al. Artificial intelligence in digital pathology-new tools for diagnosis and precision oncology. Nat Rev Clin Oncol. 16, 703–715 (2019).
  22. Indexed at, Google Scholar, Crossref

  23. Najafabadipour M, Zanin M, Rodríguez González A et al. Reconstructing the patient’s natural history from electronic health records. Artif Intell Med. 105, 101860 (2020).
  24. Indexed at, Google Scholar, Crossref

  25. Sharpless NE, Singer DS. Progress and potential: The Cancer Moonshot. Cancer Cell. 39, 889–894(2021).
  26. Indexed at, Google Scholar, Crossref

  27. Mullard A. Half of top cancer studies fail high-profile reproducibility effort. Nature. 600, 368–369(2021).
  28. Indexed at, Google Scholar, Crossref

  29. Almaida Pagan PF, Torrente M, Campos M et al. Chronodisruption and Ambulatory Circadian Monitoring in Cancer Patients: Beyond the Body Clock. Curr Oncol Rep. 24, 135–149(2022).
  30. Indexed at, Google Scholar, Crossref

Awards Nomination 20+ Million Readerbase

Select your language of interest to view the total content in your interested language

Google Scholar citation report
Citations : 67

Journal of Pharmaceutical Research and Clinical Practice received 67 citations as per Google Scholar report

Journal of Pharmaceutical Research and Clinical Practice peer review process verified at publons

Indexed In